Literature DB >> 100815

The production of morphine tolerance and physical dependence by the oral route in the rat. A comparative study.

V O Fuentes, W B Hunt, J Crossland.   

Abstract

A method for the chronical administration of morphine by the oral route is discussed and compared with the production of physical dependence to morphine by injection. The method recommends the administration of Morphine HCl dissolved in a 45% sucrose syrup and given orally for 4 weeks. The initial concentration of morphine in the syrup was 1 mg/ml and was increased weekly up to 4 mg/ml at the end of the experiment. This procedure rendered the animals physically dependent on morphine as observed by drug withdrawal, when abstinence symptoms were easily identified.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100815     DOI: 10.1007/bf00428032

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal.

Authors:  L M GUNNE
Journal:  Acta Physiol Scand Suppl       Date:  1963

2.  Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal.

Authors:  L M GUNNE
Journal:  Nature       Date:  1959-12-19       Impact factor: 49.962

3.  Letter: Enhanced utilization of brain acetylcholine during morphine withdrawal in the rat.

Authors:  E F Domino; A E Wilson
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

4.  Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice.

Authors:  H N Bhargava; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1972-10       Impact factor: 4.030

5.  Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds.

Authors:  O J Lorenzetti; L F Sancilio
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-02

6.  Temperature responses in the rat following intracerebral microinjection of morphine.

Authors:  V J Lotti; P Lomax; R George
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

7.  The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.

Authors:  K J Rogers; J A Thornton
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

8.  Factors affecting voluntary morphine intake in self-maintained addicted rats.

Authors:  J R Weeks; R J Collins
Journal:  Psychopharmacologia       Date:  1964-10-14

9.  Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal.

Authors:  G Gianutsos; M D Hynes; R B Drawbaugh; H Lal
Journal:  Psychopharmacologia       Date:  1975-07-23

10.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

View more
  5 in total

1.  Behavioral effects of low, acute doses of morphine in nontolerant groups of rats in an open-field test.

Authors:  E Schiørring; A Hecht
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

2.  Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water.

Authors:  A A Badawy; C M Evans; M Evans
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

3.  Effects of morphine on cardiovascular responses to acute myocardial ischaemia in rats.

Authors:  M Y Chan; S Dai; W W Ko
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

Review 4.  Are astroglial cells involved in morphine tolerance?

Authors:  L Rönnbäck; E Hansson
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

5.  Biphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokine/chemokine protein array analysis.

Authors:  Jui-An Lin; Jenn-Han Chen; Yuan-Wen Lee; Chao-Shun Lin; Ming-Hui Hsieh; Chuen-Chau Chang; Chih-Shung Wong; Judy Ju-Yi Chen; Geng-Chang Yeh; Feng-Yen Lin; Ta-Liang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.